Figure 2
Figure 2. Distribution of de novo, non-DS AML patients with known FAB classification enrolled on studies CCG-2891 and CCG-2961.

Distribution of de novo, non-DS AML patients with known FAB classification enrolled on studies CCG-2891 and CCG-2961.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal